The COVID-19-Associated Mucormycosis with Cutaneous Involvement.
Neel Prabha, R. D. Arora, Anju George C, A. Wankhade, Ashish Kumar Gupta, R. Gupta, N. Nagarkar
2024SKINmed
tlooto Summary
A case series of eight patients of CAM with secondary cutaneous mucormycosis is accounted, accounting a case series of eight patients of CAM with secondary cutaneous mucormycosis.
Abstract
Mucormycosis is an invasive fungal infection caused by fungi of the order Mucorales. During the coronavirus disease 2019 (COVID-19), a rise in the number of COVID-19-associated mucormycosis (CAM) patients was reported globally. Cutaneous mucormycosis is the third most common presentation of mucormycosis. It is classified as primary cutaneous and secondary cutaneous mucormycosis. The secondary form is more common than the primary cutaneous; however, most reports and case series in the literature are that of primary cutaneous mucormycosis. We accounted a case series of eight patients of CAM with secondary cutaneous mucormycosis.
Citation format
PRABHA, Neel, et al. The COVID-19-Associated mucormycosis with cutaneous involvement. SKINmed, 2024, 22 5: 346–350.